> Medication Updates
DEA Pharmacists' Manual
FDA Medication Updates
NIMH Mental Health Medications Guide
First-Generation vs Second-Generation Antipsychotics in Adults: Comparative Effectiveness
AHRQ clinician summary of systematic review examining their comparative effectiveness, benefits, and adverse effects.
FDA approves Targiniq ER
Targiniq ER is an extended-release pain reliever with abuse-deterrent properties - contains oxycodone and naloxone.
Tramadol placed in Schedule IV of Controlled Substances Act
Schedule IV controlled substances regulatory requirements apply to tramadol as of 8/18/14.
View all tags